734 related articles for article (PubMed ID: 26141072)
1. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
[TBL] [Abstract][Full Text] [Related]
2. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.
Piitulainen E; Mostafavi B; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2017; 12():495-500. PubMed ID: 28203073
[TBL] [Abstract][Full Text] [Related]
3. CT scan appearance, densitometry, and health status in protease inhibitor SZ alpha1-antitrypsin deficiency.
Holme J; Stockley RA
Chest; 2009 Nov; 136(5):1284-1290. PubMed ID: 19892672
[TBL] [Abstract][Full Text] [Related]
4. Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency; Comparison of the Characteristics of PISZ and PIZZ Individuals.
Lara B; Miravitlles M
COPD; 2015 May; 12 Suppl 1():27-31. PubMed ID: 25938288
[TBL] [Abstract][Full Text] [Related]
5. Intensive smoking diminishes the differences in quality of life and exacerbation frequency between the alpha-1-antitrypsin deficiency genotypes PiZZ and PiSZ.
Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R; Fähndrich S
Respir Med; 2017 Sep; 130():1-8. PubMed ID: 29206626
[TBL] [Abstract][Full Text] [Related]
6. The impact of smoke exposure on the clinical phenotype of alpha-1 antitrypsin deficiency in Ireland: exploiting a national registry to understand a rare disease.
O'Brien ME; Pennycooke K; Carroll TP; Shum J; Fee LT; O'Connor C; Logan PM; Reeves EP; McElvaney NG
COPD; 2015 May; 12 Suppl 1():2-9. PubMed ID: 25938284
[TBL] [Abstract][Full Text] [Related]
7. Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency.
Mostafavi B; Diaz S; Piitulainen E; Stoel BC; Wollmer P; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2018; 13():3689-3698. PubMed ID: 30510411
[TBL] [Abstract][Full Text] [Related]
8. Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age.
Piitulainen E; Montero LC; Nystedt-Düzakin M; Stoel BC; Sveger T; Wollmer P; Tanash HA; Diaz S
COPD; 2015 Apr; 12(2):162-7. PubMed ID: 25280185
[TBL] [Abstract][Full Text] [Related]
9. Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease.
Serban KA; Pratte KA; Strange C; Sandhaus RA; Turner AM; Beiko T; Spittle DA; Maier L; Hamzeh N; Silverman EK; Hobbs BD; Hersh CP; DeMeo DL; Cho MH; Bowler RP
EBioMedicine; 2022 Oct; 84():104262. PubMed ID: 36155958
[TBL] [Abstract][Full Text] [Related]
10. Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency.
Franciosi AN; Hobbs BD; McElvaney OJ; Molloy K; Hersh C; Clarke L; Gunaratnam C; Silverman EK; Carroll TP; McElvaney NG
Am J Respir Crit Care Med; 2020 Jul; 202(1):73-82. PubMed ID: 32197047
[No Abstract] [Full Text] [Related]
11. An association between plasma levels of α2-macroglobulin and α1-antitrypsin in PiMM and PiZZ individuals differing in COPD presentation.
Lechowicz U; Martinez-Delgado B; Liu B; Wrenger S; Rozy A; Zdral A; DeLuca DS; Welte T; Janciauskiene S; Chorostowska-Wynimko J
Clin Biochem; 2024 Apr; 126():110736. PubMed ID: 38428450
[TBL] [Abstract][Full Text] [Related]
12. CT lung densitometry in young adults with alpha-1-antitrypsin deficiency.
Bernspång E; Diaz S; Stoel B; Wollmer P; Sveger T; Piitulainen E
Respir Med; 2011 Jan; 105(1):74-9. PubMed ID: 20674322
[TBL] [Abstract][Full Text] [Related]
13. The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.
Tanash HA; Nystedt-Düzakin M; Montero LC; Sveger T; Piitulainen E
Ann Am Thorac Soc; 2015 Jun; 12(6):807-12. PubMed ID: 25803183
[TBL] [Abstract][Full Text] [Related]
14. Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?
Carleo A; Chorostowska-Wynimko J; Koeck T; Mischak H; Czajkowska-Malinowska M; Rozy A; Welte T; Janciauskiene S
Int J Chron Obstruct Pulmon Dis; 2017; 12():829-837. PubMed ID: 28331304
[TBL] [Abstract][Full Text] [Related]
15. Blood monocyte profiles in COPD patients with PiMM and PiZZ α1-antitrypsin.
Stolk J; Aggarwal N; Hochnadel I; Wrenger S; Martinez-Delgado B; Welte T; Yevsa T; Janciauskiene S
Respir Med; 2019 Mar; 148():60-62. PubMed ID: 30827477
[TBL] [Abstract][Full Text] [Related]
16. Respiratory symptoms and lung function in 30-year-old individuals with alpha-1-antitrypsin deficiency.
Bernspång E; Sveger T; Piitulainen E
Respir Med; 2007 Sep; 101(9):1971-6. PubMed ID: 17532199
[TBL] [Abstract][Full Text] [Related]
17. Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiency.
Jarosch I; Hitzl W; Koczulla AR; Wencker M; Welte T; Gloeckl R; Janciauskiene S; Kenn K
Respir Med; 2017 Sep; 130():98-101. PubMed ID: 29206641
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in alpha-1-antitrypsin deficiency lung disease-analysis from the German registry.
Fähndrich S; Herr C; Greulich T; Seibert M; Lepper PM; Bernhard N; Lützow C; Vogelmeier C; Bals R
COPD; 2015 May; 12 Suppl 1():58-62. PubMed ID: 25938294
[TBL] [Abstract][Full Text] [Related]
19. Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42.
Schramm GR; Mostafavi B; Piitulainen E; Wollmer P; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2021; 16():3477-3485. PubMed ID: 34992356
[TBL] [Abstract][Full Text] [Related]
20. ICS Use May Modify FEV1 Decline in α1-Antitrypsin Deficiency Patients with Relatively High Blood Eosinophils.
Low EV; Hughes SM; Zaffarullah S; Kantas D; Stockley RA; Turner AM
Respiration; 2018; 95(2):114-121. PubMed ID: 29253843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
